The humoral immune response to the antigen immobilized on nanoparticles of copolymer of polylactic acid and polyethylene glycol


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Currently, polymer nano-and microparticles are a promising material for the targeted delivery of drugs to human organs and tissues. The influence of these particles on humoral and cellular immune responses has not been studied. The aim of the study. The aim of the work was to study the immunogenicity of the protein associated with polymer biodegradable nanoparticles based on polylactic acid copolymer with polyethylene glycol. Methods. Activated nanoparticles were used for covalent binding of the model protein. Two groups of 40 mice were immunized. Nanoparticles from the copolymer of polylactic acid and polyethylene glycol, which were covalently bound to the model protein, were introduced to the experiment group. The control group was immunized with a mixture of the same protein and unmodified nanoparticles. 4 immunizations were carried out at intervals of 2 weeks. Blood sampling of mice was carried out 13 days after each immunization. The content of specific antibodies to the model antigen in the serum of mice was determined by the ELISA method. Results. According to confocal microscopy, the model protein fi2M-sfGFP was strongly adsorbed on the surface of nanoparticles. The amount of immobilized protein was shown to amount of 10 ^g per 1 mg of nanoparticles. aonclusion. Using the non-parametric statistical Mann-Whitney test, it was shown that at each stage of immunization the content of antibodies in the control group was significantly higher than in the experiment group (p<0,001).

Full Text

Restricted Access

About the authors

R. G Sakhabeev

Institute of Experimental Medicine

D. S Polyakov

Institute of Experimental Medicine

N. A Grudinina

Institute of Experimental Medicine

A. A Vishnya

Herzen State Pedagogical University of Russia

A. A Kozlovskaia

Peter the Great St. Petersburg Polytechnic University

E. S Sinitsyna

St. Petersburg State University; Institute of Macromolecular Compounds of the Russian Academy of Sciences

V. A Korzhikov-Vlakh

St. Petersburg State University

T. B Tennikova

St. Petersburg State University

M. M Shavlovsky

institute of Experimental Medicine; I.I. Mechnikov North-Western State Medical University

References

  1. Фараонова ТЕ., Оленина Л.В., Колесанова Е.Ф. Возможные клеточные рецепторы вируса гепатита С. Биомедицинская химия. 2008; 54 (2): 154-66
  2. Myszka D. G., Sweet R. W., Hensley P., Brigham-Burke M., Kwong P. D., Hendrickson W. A., Doyle M. L. Energetics of the HIV gp120-CD4 binding reaction. Proceedings of the National Academy of Sciences. 2000; 97 (16): 9026-31
  3. Гурцевич В.Э., Демина Е.А., Сенюта Н.Б., Ботезату И.В., Смирнова К.В., Душенькина Т.Е., Максимович Д.М., Парамонова У.В., Монин И.С., Лихтенштейн А.В.Вирус Эпштейна-Барр у больных классической лимфомой Ходжкина. Клиническая онкогематология. фундаментальные исследования и клиническая практика. 2018; 11 (2): 160-6
  4. Боровая Т.Г. К вопросу о роли клеточных рецепторов во взаимодействии с вирусами простого герпеса. Морфологические ведомости. 2013; 4: 116-28
  5. Богачек М.В., Зайцев Б.Н., Секацкий СХ., Протопопова Е.В., Терновой В.А., Иванова А.В., Качко А.В., Иванисенко В.А., Дитлер Г., Локтев В.Б. Характеристика С-концевой части гликопротеина Е вируса Западного Нила и оценка силы его взаимодействия с aVB3 интегрином как с предполагаемым клеточным рецептором Биохимия. 2010; 75 (4): 571-81
  6. Ne Raux H.L., Flamand A., Blondel D. Interaction of the Rabies Virus P Protein with the LC8 Dynein Light Chain. J. of virology. 2000; 74 (21): 10212-6 https://doi.org/10.1128/ JVI.74.21.10212-10216.2000
  7. Calzoni E., Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C. Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies. J. Funct Biomater. 2019; 10 (4) https://doi.org/10.3390/jfb10010004.
  8. Solovyov K.V., Polyakov D.S., Grudinina N.A., Egorov VV, Morozova I.V, Aleynikova TD. and Shavlovsky M.M. Expression in E. coli and purification of the fibrillogenic fusion proteins TTR-sfGFP and B2M-sfGFP. Preparative biochemistry and biotechnology. 2011; 41 (4): 337-49. http:// www.ncbi.nlm.nih.gov/pubmed/21967335
  9. Поляков Д.С., Антимонова О.И., Сахабеев Р.Г., Грудинина Н.А., Ходова А.Е., Синицына Е.С., Коржиков-Влах В.А., Тенникова Т.Б., Шавловский М.М. Влияние наночастиц из полимолочной кислоты на иммуногенность связанного с ними белка. Инфекция и иммунитет. 2017; 7 (2): 123-9. https://doi. org/10.15789/2220-7619-2017-2-123-129
  10. Поляков Д.С., Грудинина Н.А., Богословская Т.Ю., Соколов А.В., Мандельштам М.Ю., Васильев В.Б. Получение в клетках HEK293 химерного белка, состоящего из рецептора LDL и EGFP; перспективная система для оценки эффектов мутаций в гене LDLR. Цитология. 2017; 59 (12): 881-7
  11. Поляков Д.С., Грудинина Н.А., Соловьев К.В., Егоров В.В., Сироткин А.К., Алейникова Т.Д., Тотолян Арег А., Шавловский М.М. Бета-2-микроглобулиновый амилоидоз: фибриллогенез природного и рекомбинантных бета-2-микроглобулинов человека. Медицинский академический журнал. 2010; 10 (2): 40-9. ISSN 1608-4101 http://elibrary.ru/ item.asp?id=22969470
  12. Поляков Д.С., Сахабеев Р.Г., Шавловский М.М. Частичная денатурация рекомбинантного белка для его аффинного выделения. Прикладная биохимия и микробиология. 2016; 52 (1): 122-7. http://elibrary.ru/item. asp?id=25069770
  13. Kirill V. Solovyov, Anna M. Kern, Natalya A. Grudinina, Tatyana D. Aleynikova, Dmitry S. Polyakov, Irina V. Morozova, Michael M. Shavlovsky. Genetic structures and conditions of their expression, which allow receiving native recombinant proteins with high output. International Journal of biomedicine. 2012; 2 (1): 45-9 http://elibrary.ru/item.asp?id=20245469 http://ijbm.org/articles/2_1_BR1.pdf

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies